Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tatiana V. Egorova
Observed names:
Egorova, Tatiana V.,
T V Egorova,
T. Egorova,
T. V. Egorova,
T.V. Egorova,
Tatiana Egorova,
Tatyana V. Egorova,
Т. Egorova
show all 8
Institutions:
Belgorod National Research University,
Russian Academy of Sciences,
Moscow State Pedagogical University,
Institute of Gene Biology
Observed institutions:
Belgorod National Research University,
Russian Academy of Sciences,
Moscow State Pedagogical University,
Interdisciplinary Scientific Center J.-V. Poncelet,
Institute of Gene Biology,
Centre d'Investigation Clinique Robert Debré
show all 6
ORCID:
0000-0002-3346-3242
Observed ORCID:
0000-0002-3346-3242
OpenAlex ID:
A5012263058
Muscle-Specific Promoters for Gene Therapy
2021
·
Victoria V. Skopenkova
, Tatiana V. Egorova
, et al.
·
Acta Naturae
·
58
PDF
Current advances in gene therapy of mitochondrial diseases
2022
·
Vladislav O. Soldatov
, Marina V. Kubekina
, et al.
·
Journal of Translational Medicine
·
46
PDF
CRISPR/Cas9-generated mouse model of Duchenne muscular dystrophy recapitulating a newly identified large 430 kb deletion in the human DMD gene
2019
·
Tatiana V. Egorova
, Evgenia D. Zotova
, et al.
·
Disease Models & Mechanisms
·
43
PDF
Therapeutic potential of highly functional codon-optimized microutrophin for muscle-specific expression
2022
·
Anna V. Starikova
, Victoria V. Skopenkova
, et al.
·
Scientific Reports
·
30
PDF
PCR-Based Analytical Methods for Quantification and Quality Control of Recombinant Adeno-Associated Viral Vector Preparations
2021
·
Anna Shmidt
, Tatiana Egorova
·
Pharmaceuticals
·
27
PDF
Emerging Technologies Tackling Adeno-Associated Viruses (AAV) Immunogenicity in Gene Therapy Applications
2025
·
Tatiana Egorova
, Anna Starikova
, et al.
·
Pharmaceutics
·
19
PDF
AAV infection of bovine embryos: Novel, simple and effective tool for genome editing
2022
·
Anna S. Krivonogova
, Alexandra V. Bruter
, et al.
·
Theriogenology
·
17
Adeno-Associated Viruses for Modeling Neurological Diseases in Animals: Achievements and Prospects
2022
·
Evgenii Lunev
, Anna Karan
, et al.
·
Biomedicines
·
17
PDF
VBIT-4 Rescues Mitochondrial Dysfunction and Reduces Skeletal Muscle Degeneration in a Severe Model of Duchenne Muscular Dystrophy
2025
·
Mikhail V. Dubinin
, Anastasia E. Stepanova
, et al.
·
International Journal of Molecular Sciences
·
13
PDF
In-Frame Deletion of Dystrophin Exons 8–50 Results in DMD Phenotype
2023
·
Tatiana V. Egorova
, Ivan I. Galkin
, et al.
·
International Journal of Molecular Sciences
·
10
PDF
CRISPR/Cas9-generated mouse model with humanizing single-base substitution in the Gnao1 for safety studies of RNA therapeutics
2023
·
Anna V. Polikarpova
, Tatiana V. Egorova
, et al.
·
Frontiers in Genome Editing
·
10
PDF
In vitro assay for the efficacy assessment of AAV vectors expressing microdystrophin
2020
·
Kirill A. Danilov
, Svetlana G. Vassilieva
, et al.
·
Experimental Cell Research
·
10
Genetically modified animal models of hereditary diseases for testing of gene-directed therapy
2022
·
Anna V. Polikarpova
, Tatiana V. Egorova
, et al.
·
Research Results in Pharmacology
·
8
PDF
Effective Viral Delivery of Genetic Constructs to Neuronal Culture for Modeling and Gene Therapy of GNAO1 Encephalopathy
2022
·
E. A. Lunev
, A. A. Shmidt
, et al.
·
Molecular Biology
·
8
Эффективная Вирусная Доставка В Нейрональную Культуру Генетических Конструкций Для Моделирования И Генной Терапии Gnao1-энцефалопатии
2022
·
E A Lunev
, A A Shmidt
, et al.
·
Molecular Biology
·
8
Development of an AAV-RNAi strategy to silence the dominant variant GNAO1 c.607G>A linked to encephalopathy
2025
·
Evgenii A. Lunev
, Natalia V. Klementieva
, et al.
·
Gene Therapy
·
6
RNA Interference Effectors Selectively Silence the Pathogenic Variant GNAO1 c.607 G > A In Vitro
2024
·
Natalia V. Klementieva
, Evgenii A. Lunev
, et al.
·
Nucleic Acid Therapeutics
·
6
CRISPR-Cas9 correction in the DMD mouse model is accompanied by upregulation of Dp71f protein
2023
·
Tatiana V. Egorova
, Anna V. Polikarpova
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
6
PDF
Adeno-associated virus vector-based gene therapy for hereditary diseases: current problems of application and approaches to solve them
2024
·
T. V. Egorova
, A. A. Piskunov
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
5
Duchenne Muscular Dystrophy Animal Models
2021
·
Tatiana V. Egorova
, Ivan I. Galkin
, et al.
·
IntechOpen eBooks
·
4
PDF
Dmd Treatment: Animal Models
2018
·
T. Egorova
, D. Reshetov
, et al.
·
Neuromuscular Disorders
·
2
Correction: Current advances in gene therapy of mitochondrial diseases
2023
·
Vladislav O. Soldatov
, Marina V. Kubekina
, et al.
·
Journal of Translational Medicine
·
1
PDF
P.393New advances in the neuromuscular diseases registry in Russia
2019
·
D. Vlodavets
, A. Monakhova
, et al.
·
Neuromuscular Disorders
·
1
Delivery of transgenes into Gαo-rich subcortical structures of the mouse brain with potential applications for GNAO1 encephalopathy
2026
·
Svetlana G. Vassilieva
, Evgenii A. Lunev
, et al.
·
Scientific Reports
PDF
Development of AVE-8063-Bearing Pt(IV) Prodrug for Dual-Action Light-Controlled Chemotherapy
2026
·
Daniil Spector
, Anastasia Zharova
, et al.
·
Russian Journal of General Chemistry
PDF
Show more works
View as search
Works count:
37
Citation count:
355
H-index:
10
I10-index:
12
Year
Topic
Type
